Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0012 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/21/15 All times are local (Market data is delayed by at least 15 minutes).

neurologix inc (NRGXQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/23/15 - $0.0040
52 Week Low
11/5/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEUROLOGIX INC (NRGXQ)

neurologix inc (NRGXQ) Related Bloomberg News

View More Bloomberg News

neurologix inc (NRGXQ) Related Businessweek News

No Related Businessweek News Found

neurologix inc (NRGXQ) Details

Neurologix, Inc., a development stage company, engages in the research and development of proprietary treatments for disorders of the brain and central nervous system primarily using gene therapies. Its treatments are designed as alternatives to conventional surgical and pharmacological treatments. The company primarily focuses on the development of a therapeutic product to meet the needs of patients suffering from Parkinson’s disease. Its core technology, NLX-P101, completed Phase II clinical trial of gene transfer for the treatment of advanced Parkinson’s disease. Neurologix also focuses on developing therapies to treat other neurodegenerative and metabolic disorders, including therapies relating to epilepsy, Huntington’s disease, and depression, as well as metabolic disorders, including genetically-based obesity. The company was founded in 1999 and is headquartered in Fort Lee, New Jersey. On March 16, 2012, Neurologix, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

12 Employees
Last Reported Date: 03/25/11
Founded in 1999

neurologix inc (NRGXQ) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NRGXQ:US $0.00 USD 0.00

NRGXQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NRGXQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation NRGXQ Industry Range
No financial data is available for NRGXQ.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROLOGIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at